NCT07088419 - "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)" | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 23, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

August 31, 2026

Conditions

Mycoplasma GenitaliumNon-gonococcal Urethritis (NGU)

Interventions

DRUG

Tinidazole

2 grams orally on day one followed by 500mg orally twice daily on days 2-10

Trial Locations (1)

RECRUITING

Harborview Medical Center, Public Health - Seattle & King County Sexual Health Clinic, Seattle